Brief: Seres Therapeutics FY EPS USD 0
13/03/2025 11:00
Mar 13 (Reuters) - Seres Therapeutics FY operating expenses USD 121.315 million. FY operating income USD -121.315 million FY net income USD 136 thousand
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47